Human Combination Vaccines Market Growth Report 2021-2026

Human Combination Vaccines Market Growth Report 2021-2026 by Type, End-User Industry, Region, and Key Companies

  • Report ID : IMR-8376 |
  • Category : Healthcare  |
  • Published Date : Jan 2021 |
  • Format :   IMR Report Formats   IMR Report Formats   IMR Report Formats

Global Human Combination Vaccines (HCV) Market Overview

The global Human Combination Vaccines market was valued at USD 5.96 billion in 2019 and is expected to reach USD 32.68 billion by the year 2026, at a CAGR of 10.3%.

A human combination vaccine is a product that protects against two or more diseases against a single one that is caused by an organism. The vaccines contain antigens that are combined, or it is mixed before administration. A combination vaccine boosts the immune system and the metabolism to fight against the diseases spread by any infection. These vaccines are injected directly or orally administered. The human vaccine is composed of the inactivated virus strain. 

The human combination vaccines market can be bifurcated into the inactivated vaccines and live attenuated vaccines. High acceptance of inactivated vaccines among physicians is attributed to the strong growth of the segment. Moreover, the inactivated vaccine is stable and can easily be stored and transported in freeze-dried form.

Hospitals are the leading segment of the market due to the increase in government awareness and initiation of different programs for immunization against various diseases. Additionally, hospitals are preferred by both patients and physicians as these are modernized with all types of vaccines. 

By the end of 2027, the Human Combination Vaccines market size is estimated to be USD 46.03 billion. The fact that it has a low risk of side effects related to vaccines is leading to a positive response from numerous demographics and growing alertness regarding vaccination by several governments and non-profit organizations are the key factors driving the human combination vaccines market.  

Human Combination Vaccines Market

Impact of COVID-19 on Human Combination Vaccines Market

The healthcare industry is growing a lot in the market due to the novel coronavirus. Due to the outbreak of the virus the economy wasn’t stable in all the countries that were witnessing the impact of COVID-19 are flourishing in the healthcare industry. The ongoing research and development that is going in the hospitals and research centers are helping the market growth across the globe. The ongoing research of the vaccine is helping the market growth in the country.

Market Segmentation

By type, the market is segmented into

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Other

By End-User Industry

  • Hospitals & Clinics,
  • Ambulatory Surgical Centers
  • Others

Regions and Countries Level Analysis:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)

Type Insights:

The Live attenuated vaccine segment is accounted for the largest segment with a market share of 64.02% and estimated to have a market size of USD 10.39 billion in the year 2026. Vaccine manufacturers are working toward the advancement of existing vaccines as well as the development of novel vaccines which is increasing the growth of the segment.

Regional Insights:

The Human Combination vaccine market is growing rapidly in the Asia-Pacific region. Asia-Pacific region is accounted for the largest market share of 47.2% across the globe with a CAGR of 9.52% and a market size of USD 7.71 billion in the year 2019. But in the forecast period, due to the high demand from the regions like China, Japan, Australia, and India, Asia-Pacific is expected to continue the growth with estimated market size of USD 20.71 billion in the year 2026.

Major Key Players Considered in the Market

  • Cadila Healthcare Ltd.,
  • CSL Ltd.,
  • Daiichi Sankyo Co. Ltd.,
  • GlaxoSmithKline plc,
  • Mass Biologics,
  • Meiji Holdings Co. Ltd.,
  • Merck & Co. Inc.,
  • Mitsubishi Tanabe Pharma Corp.,
  • Sanofi,
  • Takeda Pharmaceutical Co. Ltd.

Salient Features of the Human Combination Vaccines Market

The approximate expected value for the Human Combination Vaccines was USD 5.96 billion in 2019, and it is expected to reach USD 32.68 billion by 2026.

  • The key advantage for human combination vaccines is that it reduces the cost of extra health care visits which are helping the consumers get easy access to the market.
  • The inactivated vaccine segment is expected to be the largest segment in the forecast period with a market share of 37.16% and an estimated market size of USD 28.06 billion in the year 2026.
  • The HCV market in the Asia Pacific is estimated to witness the strongest growth. The sudden increase of various diseases such as polio, flu, and rotavirus, and government efforts toward immunization boost the growth of the market.

Frequently Asked Questions :

1.  Market Overview 

 1.1 Product Overview and Scope of Market 

1.2 Global Market Value & Forecast 

 1.3 Key Insight 

2.  Market Insights by Product Type 

 2.1 Global Market Revenue by Product Types: 

2.1.1 Global Market Revenue (in million USD) by Product Types (Historic Data)

2.1.2 Global Market Revenue ( in million USD) by Product  Types (Current &  Forecast  Data) 

2.1.3 Global Market Share (%) by Product  Types in 2018 

2.1.4 Global Market Production  (in million Units) by Product Types (Historic Data) 

2.1.5 Global Market Production  (in million Units) by Product Types (Current and Forecasted Data) 

2.2Inactivated Vaccines

2.2.1 Inactivated Vaccines Revenue (in million USD ) (2019-27)

2.2.2 Inactivated Vaccines Volume (in million Units) (2019-27) 

2.2.3 Inactivated Vaccines Geographical Analysis (Value)

2.2.4 Inactivated Vaccines Geographical Analysis (Volume) 

2.3Live Attenuated Vaccines

2.3.1 Live Attenuated Vaccines Revenue (in million USD ) (2019-27)

2.3.2 Live Attenuated Vaccines Volume (in million Units) (2019-27) 

2.3.3 Live Attenuated Vaccines Geographical Analysis (Value)

2.3.4 Table Live Attenuated Vaccines Geographical Analysis (Volume) 


2.4.1 Other Revenue (in million USD ) (2019-27)

2.4.2 Other Volume (in million Units) (2019-27) 

2.4.3 Other Geographical Analysis (Value)

2.4.4 Other Geographical Analysis (Volume) 

3.  Market Insights by Application

 3.1 Global Market Revenue by Applications: 

3.1.1  Global Market Revenue (in million USD) by Applications (Historic Data)

3.1.2  Global Market Revenue ( in million USD) by Applications (Current &  Forecast  Data) 

3.1.3 Global Market Share (%) by Application in 2018 

3.1.4 Global Market Volume  (in million Units) by Application (Historic Data) 

3.1.5 Global Market Volume  (in million Units) by Applications (Current and Forecasted Data) 

3.2 Hospitals

3.2.1  Hospitals Revenue (in million USD ) (2019-27)

3.2.2  Hospitals Volume (in million Units) (2019-27) 

3.2.3  Hospitals Geographical Analysis (Value)

3.2.4  Hospitals Geographical Analysis (Volume) 


3.3.1  Clinics Revenue (in million USD ) (2019-27)

3.3.2  Clinics Volume (in million Units) (2019-27) 

3.3.3 Table Clinics Geographical Analysis (Value)

3.3.4 Table Clinics Geographical Analysis (Volume) 


3.4.1 Graph Others Revenue (in million USD ) (2019-27)

3.4.2 Graph Others Volume (in million Units) (2019-27) 

3.4.3  Others Geographical Analysis (Value)

3.4.4  Others Geographical Analysis (Volume) 

4.  Regional Outlook

 4.1 Global Market Revenue (In Million USD) by Regions Historical (2014-2018)

4.2 Global Market Volume (In Million Units) by Regions Historical (2014-2018) 

4.3 Global Market Revenue (In Million USD) by Regions Forecast (2019-2027) 

4.4 Global Market Volume (In Million Units) by Regions Forecast (2019-2027)

4.5 North America Market Revenue Forecast (2019-2027)

4.6 Europe Market Revenue Forecast (2019-2027)

4.7 APAC Market Revenue Forecast (2019-2027) 

4.8 Rest of the World (ROW) Market Revenue Forecast (2019-2027) 

5.  Competitive Intelligence

5.1 GlaxoSmithKline

5.1.1 Overview:

5.1.2 Basic Company Information

5.1.3 Financial Overview

5.1.4 Geography Revenue Mix

5.1.5 Business Revenue Mix

5.1.6 Recent Development

5.2 Merck

5.3 Sanofi

5.4 Daiichi Sankyo

5.5 Takeda Pharmaceuticals








6.  Manufacturing Cost Analysis

6.1 Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trends of Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.2 Manufacturing Cost Structure

7.  Industrial Chain Analysis

7.1 Raw Materials Major Manufacturers

7.2 Top Downstream Buyers

8.  Marketing Strategy

8.1 Marketing Channel

8.1.1 Direct Marketing 

8.1.2 Indirect Marketing 

8.2 Market Positioning

8.2.1 Pricing Strategy 

8.2.2 Brand Strategy 

8.2.3 Target Client 

8.3 Distribution Insight

9.  Methodology and Data Source

9.1 Methodology/Research Approach

9.2 Research Programs/Design 

9.3 Market Breakdown and Data Triangulation 

9.4 Data Source

9.4.1 Secondary Sources 

9.4.2 Primary Sources 

9.6 Disclaimer

List of Tables

North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.)
List of Figure

GlaxoSmithKline, Merck, Sanofi, Daiichi Sankyo, Takeda Pharmaceuticals

Inquiry Before Buying


For startups and educational institutions.

Request Discount 


IMR offers custom market research services as per customer requirements.

Request Customization 

Why Choose Us

Reliable Market Service

We provide accurate market insights and effective consulting to achieve your goals.

Holistic Market View

We provide in-depth knowledge of the market which enables our clients to take informed decisions at minimum risks.

Innovative Methodology

Our world class researchers use big data and advanced analytics to not only provide accurate insights, but spot future trends and help you you grow.

Customer Centric

We strive to deliver deep understanding of the elements which are pivotal to prosperity of our clients.

24/7 Support

Our dedicated support team is here to help you in every aspect.

Introspective Market Research
Loading....Please Wait